Biophys J, August 2001, p. 697-709, Vol. 81, No. 2

Probing the Origins of Increased Activity of the E22Q "Dutch" Mutant Alzheimer's -Amyloid Peptide

Department of Chemistry, Boston University, Boston, Massachusetts 02215 USA

The amyloid peptide congener A(10-35)-NH₂ is simulated in an aqueous environment in both the wild type (WT) and E22Q "Dutch" mutant forms. The origin of the noted increase in deposition activity resulting from the Dutch mutation is investigated. Multiple nanosecond time scale molecular dynamics trajectories were performed and analyzed using a variety of measures of the peptide's average structure, hydration, conformational fluctuations, and dynamics. The results of the study support the conclusions that 1) the E22Q mutant and WT peptide are both stable in "collapsed coil" conformations consistent with the WT structure of Zhang et al. (2000, J. Struct. Biol. 130:130-141); 2) the E22Q peptide is more flexible in solution, supporting early claims that its equilibrium structural fluctuations are larger than those of the WT peptide; and 3) the local E22Q mutation leads to a change in the first solvation layer in the region of the peptide's "hydrophobic patch," resulting in a more hydrophobic solvation of the mutant peptide. The simulation results support the view that the noted increase in activity due to the Dutch mutation results from an enhancement of the desolvation process that is an essential step in the aggregation of the peptide.

Biophys J, August 2001, p. 697-709, Vol. 81, No. 2
© 2001 by the Biophysical Society   0006-3495/01/08/697/13  $2.00

This article has been cited by other articles:

				L. Cruz, B. Urbanc, J. M. Borreguero, N. D. Lazo, D. B. Teplow, and H. E. Stanley Solvent and mutation effects on the nucleation of amyloid {beta}-protein folding PNAS, December 20, 2005; 102(51): 18258 - 18263. [Abstract] [Full Text] [PDF]

				Y. Xu, J. Shen, X. Luo, W. Zhu, K. Chen, J. Ma, and H. Jiang Conformational transition of amyloid {beta}-peptide PNAS, April 12, 2005; 102(15): 5403 - 5407. [Abstract] [Full Text] [PDF]

				H. D. Nguyen and C. K. Hall Kinetics of Fibril Formation by Polyalanine Peptides J. Biol. Chem., March 11, 2005; 280(10): 9074 - 9082. [Abstract] [Full Text] [PDF]

				T. J. Nelson and D. L. Alkon Oxidation of Cholesterol by Amyloid Precursor Protein and {beta}-Amyloid Peptide J. Biol. Chem., February 25, 2005; 280(8): 7377 - 7387. [Abstract] [Full Text] [PDF]

				H. D. Nguyen and C. K. Hall Phase Diagrams Describing Fibrillization by Polyalanine Peptides Biophys. J., December 1, 2004; 87(6): 4122 - 4134. [Abstract] [Full Text] [PDF]

				L. Morelli, R. Llovera, S. A. Gonzalez, J. L. Affranchino, F. Prelli, B. Frangione, J. Ghiso, and E. M. Castano Differential Degradation of Amyloid {beta} Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading Enzyme J. Biol. Chem., June 20, 2003; 278(26): 23221 - 23226. [Abstract] [Full Text] [PDF]

				F. Massi, D. Klimov, D. Thirumalai, and J. E. Straub Charge states rather than propensity for {beta}-structure determine enhanced fibrillogenesis in wild-type Alzheimer's {beta}-amyloid peptide compared to E22Q Dutch mutant Protein Sci., July 1, 2002; 11(7): 1639 - 1647. [Abstract] [Full Text] [PDF]